To hear about similar clinical trials, please enter your email below
Trial Title:
Physical Activity, Kinesiophobia, and Stoma Compliance in Urostomy Patients
NCT ID:
NCT06541821
Condition:
Bladder Cancer
Conditions: Official terms:
Urinary Bladder Neoplasms
Kinesiophobia
Study type:
Observational
Overall status:
Enrolling by invitation
Study design:
Time perspective:
Prospective
Intervention:
Intervention type:
Other
Intervention name:
survey evaluation
Description:
assessment of physical activity, fear of movement, and ostomy compliance
Arm group label:
Control Group
Arm group label:
Urostomy Patients Group
Summary:
In this study, it is aimed to determine the level of physical activity, to investigate
kinesiophobia, to determine compliance with the stoma and to compare with healthy
controls in patients with bladder cancer who have undergone urostomy surgery and live
with a stoma.
Criteria for eligibility:
Study pop:
Patients using ostomy after Urostomy Surgeries for Bladder Cancer
Sampling method:
Probability Sample
Criteria:
Inclusion Criteria:
- The patient group will include people between the ages of 40-75 who underwent
urostomy surgery and a stoma after being diagnosed with bladder cancer.
- The control group will include age-matched healthy people with similar age, body
weight and height, without a previous history of cancer.
Exclusion Criteria:
- Orthotopic surgeries will not be included in the patient group
- Being under the age of 40,
- Being diagnosed with lymphedema,
- Presence of active metastasis,
- Neurological pathologies that limit voluntary mobility,
- Orthopedic and cardiovascular pathologies,
- Having a learning disability or other cognitive or communication impairment.
- The control group will be excluded if they have any history of cancer.
Gender:
All
Minimum age:
40 Years
Maximum age:
75 Years
Healthy volunteers:
Accepts Healthy Volunteers
Locations:
Facility:
Name:
Selcuk University
Address:
City:
Konya
Zip:
42130
Country:
Turkey
Start date:
August 2, 2024
Completion date:
September 15, 2024
Lead sponsor:
Agency:
Selcuk University
Agency class:
Other
Source:
Selcuk University
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06541821